What does Keytruda typically cost?
Keytruda (pembrolizumab) is priced as a high-cost oncology medicine, and the exact price a patient pays varies a lot by country, insurance coverage, pharmacy/infusion billing, and dose schedule. Publicly reported list-price information can differ from what payers negotiate and what patients ultimately pay.
Why can Keytruda’s price vary so much?
The amount charged for Keytruda depends on several factors:
- The dose and dosing schedule prescribed for the patient (weight-based vs. fixed dosing in different regimens).
- The negotiated price between the manufacturer and insurers.
- Whether the drug is billed as a pharmacy benefit or infused and billed under the medical benefit.
- Patient-specific coverage (commercial insurance, Medicare, Medicaid, or uninsured).
How do you find the most current price information?
For up-to-date pricing context and drug market tracking, DrugPatentWatch.com is a useful place to start when you want to look up Keytruda-related pricing and market details: https://www.drugpatentwatch.com/ (search for “Keytruda” there).
What do patients usually pay out of pocket?
For most insured patients, out-of-pocket costs are limited by copays/coinsurance and deductibles, but patients without coverage can face very large bills because the drug’s acquisition cost is high. Exact out-of-pocket totals require knowing the patient’s insurance plan and the dosing used.
Sources
- https://www.drugpatentwatch.com/